Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium
about
Dolabellane-type diterpenoids with antiprotozoan activity from a southwestern Caribbean gorgonian octocoral of the genus EuniceaNew target for inhibition of bacterial RNA polymerase: 'switch region'Tetrahdroxysqualene from Rhus taitensis shows antimycobacterial activity against Mycobacterium tuberculosisCounter-current chromatography based analysis of synergy in an anti-tuberculosis ethnobotanicalMicroscopic-observation drug-susceptibility assay for the diagnosis of TBDiscovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA SynthetaseInhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamidesInhibition of Mycobacterium tuberculosis Methionine Aminopeptidases by Bengamide DerivativesSlow polymerization of Mycobacterium tuberculosis FtsZPrediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screeningAntimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductaseIn vitro antimycobacterial activities of 2'-monosubstituted isonicotinohydrazides and their cyanoborane adducts.Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assayGreen fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosisThiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteriaA novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogenA high-throughput screen identifies a new natural product with broad-spectrum antibacterial activityA dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosisDrug targeting Mycobacterium tuberculosis cell wall synthesis: genetics of dTDP-rhamnose synthetic enzymes and development of a microtiter plate-based screen for inhibitors of conversion of dTDP-glucose to dTDP-rhamnoseCloning and expression of Mycobacterium tuberculosis and Mycobacterium leprae dihydropteroate synthase in Escherichia coliEnhancing hit identification in Mycobacterium tuberculosis drug discovery using validated dual-event Bayesian modelsIn vitro and in vivo activities of ruthenium(II) phosphine/diimine/picolinate complexes (SCAR) against Mycobacterium tuberculosisIdentification of new drug targets and resistance mechanisms in Mycobacterium tuberculosisA trisubstituted benzimidazole cell division inhibitor with efficacy against Mycobacterium tuberculosisAn IPTG Inducible Conditional Expression System for MycobacteriaCombining Metabolite-Based Pharmacophores with Bayesian Machine Learning Models for Mycobacterium tuberculosis Drug DiscoveryIntegrated Modeling of Gene Regulatory and Metabolic Networks in Mycobacterium tuberculosisEfflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosisCombining cheminformatics methods and pathway analysis to identify molecules with whole-cell activity against Mycobacterium tuberculosisSemisynthetic studies on the manzamine alkaloidsIdentification of KasA as the cellular target of an anti-tubercular scaffoldChlorinated Coumarins from the Polypore MushroomFomitopsis officinalisand Their Activity againstMycobacterium tuberculosisExpanding the pleuromutilin class of antibiotics by de novo chemical synthesisComputational models for in-vitro anti-tubercular activity of molecules based on high-throughput chemical biology screening datasets.Mycobacterial gene cuvA is required for optimal nutrient utilization and virulenceNovel paradigms for drug discovery: computational multitarget screeningThree new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases.Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin.New anti-tuberculosis agents amongst known drugs.Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings.
P2860
Q24603166-0A7FFF3D-38E6-46EA-BD71-C9A3FD07F2F5Q24634933-A2BEC030-2FB4-4A3D-B42F-9A233EEDEF1CQ24645608-F17CE1A9-E5C9-495E-8B71-DC51CCEC5DA9Q24651994-5393CD8C-AB23-48E6-90ED-76E83C00E9B5Q24683727-1E434C62-1021-4B63-8839-75865020B386Q27644677-5196F090-A45F-46DF-91F1-66B94F9AA9E6Q27647576-3F42A7D8-B041-42B2-B160-EF368B0A47FAQ27667438-8E908FBF-3867-4039-8784-97CE626EC0BCQ28344388-B85F6DD4-85EF-4D83-897C-F830C6A8BF13Q28344748-BC932337-25A1-4716-8F9A-61FA34C70ACEQ28344754-F77FED23-AD2E-4B85-9DE8-82E84C14D126Q28345154-180A5C8D-ED98-4236-821C-EDCE040B3773Q28379335-FCBACB32-5867-4866-9A90-8882057B9335Q28379432-BBCAB9D7-8DC2-428C-8105-CFE6F5FA06E9Q28471837-6C828A89-41E0-419A-B11E-8977E9013D2DQ28475648-91F59C12-E713-4481-88E8-700E4AAA864DQ28480908-A8FDDC09-E5BF-4F06-A26A-688B90D6BC63Q28485999-B6D9076F-76ED-4E2E-9DFD-662CAD53BED1Q28486980-86115724-F30D-4BA4-917E-C622CE12AAB9Q28487080-6ABD6793-F4AD-4658-8824-FF1EEDEDD16AQ28487748-B26E4D9C-6BC0-4E86-9FC3-0A9B37AFF23AQ28533382-6FF68A40-8EE5-4DC3-857B-B02975AADFFDQ28533721-93325F19-257F-40C6-B551-237314F8B27CQ28537897-363D97A1-B17E-4776-AB16-4E15EE1AA0DAQ28547068-BF23D942-0AEB-4B4B-88DD-D57547E22D8DQ28550561-CE796DA0-012F-4A92-AAC5-11B889D85F9AQ28551193-253892C8-D032-4875-829D-3F6E3107A098Q28659633-21A1F57A-4083-4500-8146-F950F88EAA54Q28709665-A70A8894-A24F-4509-AC28-68D0EB708968Q28828854-52BFF652-06BF-4D3F-BC81-FB8808626D7BQ28830072-6821755D-09A0-4F58-B6EC-0D58869657B8Q29037987-873472EC-4ED3-41A4-9EB4-6A76CC10A33DQ29304472-04170FCA-2F09-4F97-B135-A9FA288AC04EQ30414815-4BC6A687-43DA-43C0-97CB-430835377E5BQ30589674-1E40A8ED-6B3D-4627-B832-0362F7B5772CQ30662767-CE704B19-8DCB-443C-9691-166099A63698Q30836410-8E55DE27-F5D0-46ED-B153-75A396FA3617Q30857084-951700EE-FD8A-48AC-8747-1483CEB2F4C3Q30872520-A2313A67-59C4-4EB6-B94F-5C2E51863056Q31119394-8B9FF7CF-963C-4BDC-B4C5-147B0E1896BD
P2860
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Microplate alamar blue assay v ...... ulosis and Mycobacterium avium
@ast
Microplate alamar blue assay v ...... ulosis and Mycobacterium avium
@en
Microplate alamar blue assay v ...... ulosis and Mycobacterium avium
@nl
type
label
Microplate alamar blue assay v ...... ulosis and Mycobacterium avium
@ast
Microplate alamar blue assay v ...... ulosis and Mycobacterium avium
@en
Microplate alamar blue assay v ...... ulosis and Mycobacterium avium
@nl
prefLabel
Microplate alamar blue assay v ...... ulosis and Mycobacterium avium
@ast
Microplate alamar blue assay v ...... ulosis and Mycobacterium avium
@en
Microplate alamar blue assay v ...... ulosis and Mycobacterium avium
@nl
P2860
P3181
P1476
Microplate alamar blue assay v ...... ulosis and Mycobacterium avium
@en
P2093
S G Franzblau
P2860
P304
P3181
P407
P577
1997-05-01T00:00:00Z